Loading the company…
Loading the company…
Families: Radiofrequency ablation (facet, genicular, basivertebral).
All companies · Product and company coverage
In the last ten years FDA made 6 decisions for Relievant Medsystems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2022 (2). The latest was on 2022-10-26.
| Family | Decisions on record |
|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 7 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2022-10-26 | 510(k) | K222281 | Intracept Intraosseous Nerve Ablation System |
| 2022-03-11 | 510(k) | K213836 | Intracept Intraosseous Nerve Ablation System |
| 2019-05-03 | 510(k) | K190504 | Intracept Intraosseous Nerve Ablation System (RF Probe), Intracept Intraosseous Nerve Ablation System (Access Instruments), Relievant RF Generator |
| 2018-09-14 | 510(k) | K180369 | Intracept Intraosseous Nerve Ablation System (component Intracept RF Probe) |
| 2017-08-18 | 510(k) | K171143 | Relievant Medsystems RF Generator |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Relievant Medsystems.